Implementation of an evidence-based "standard operating procedure" and outcome in septic shock

被引:238
作者
Kortgen, A
Niederprüm, P
Bauer, M
机构
[1] Univ Jena, Dept Anaesthesiol & Intens Care Therapy, D-07740 Jena, Germany
[2] Univ Saarland, Dept Anaesthesiol & Intens Care Med, Homburg, Germany
关键词
standard operating procedure; quality management; early goal directed therapy; hydrocortisone; intensive insulin therapy; recombinant human activated protein C;
D O I
10.1097/01.CCM.0000206112.32673.D4
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To assess the impact of an algorithm defining resuscitation according to early goal-directed therapy, glycemic control, administration of stress doses of hydrocortisone, and use of recombinant human activated protein C (rhAPC) on measures of organ dysfunction and outcome in septic shock. Design: Retrospective cohort study. Setting: Multidisciplinary ten-bed intensive care unit of a university hospital. Patients: Sixty patients were analyzed: 30 consecutive patients fulfilling criteria for diagnosis of septic shock, treated from September 2002 until December 2003 after implementation of a standard operating procedure (SOP) for severe sepsis and septic shock; and 30 patients with septic shock treated from January until August 2002 in the same unit, who served as controls. Measurements and Results: Data for blood gas analysis, lactate, glucose, serum creatinine, bilirubin, white blood cells, platelets, and C-reactive protein were obtained from patient files on admission or at time of diagnosis of septic shock and at 7:00 a.m. on days 2 and 4; Sequential Organ Failure Assessment scores were calculated and 28-day survival was assessed. With implementation of the SOP, use of dobutamine (12/30 vs. 2/30), insulin (blood glucose < 150 mg/dL, day 4: 26/28 vs. 13/25), hydrocortisone (30/30 vs. 13/30), and rhAPC (7/30 vs. 0/30) significantly increased, whereas volume for resuscitation and use of packed red blood cells were unaffected. Mortality was 53% in the historical control group and 27% after implementation of the SOP (p < .05). Conclusion: The combined approach of early goal-directed therapy, intensive insulin therapy, hydrocortisone administration, and additional application of rhAPC in selected cases seems to favorably influence outcome. The implementation of a "sepsis bundle" can be facilitated by a standardized protocol while significantly reducing the time until the defined therapeutic measures are realized in daily practice.
引用
收藏
页码:943 / 949
页数:7
相关论文
共 24 条
  • [1] *AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801
  • [2] Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock
    Annane, D
    Sébille, V
    Charpentier, C
    Bollaert, PE
    François, B
    Korach, JM
    Capellier, G
    Cohen, Y
    Azoulay, E
    Troché, G
    Chaumet-Riffaut, P
    Bellissant, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07): : 862 - 871
  • [3] Efficacy and safety of recombinant human activated protein C for severe sepsis.
    Bernard, GR
    Vincent, JL
    Laterre, P
    LaRosa, SP
    Dhainaut, JF
    Lopez-Rodriguez, A
    Steingrub, JS
    Garber, GE
    Helterbrand, JD
    Ely, EW
    Fisher, CJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) : 699 - 709
  • [4] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [5] Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study
    Briegel, J
    Forst, H
    Haller, M
    Schelling, G
    Kilger, E
    Kuprat, G
    Hemmer, B
    Hummel, T
    Lenhart, A
    Heyduck, M
    Stoll, C
    Peter, K
    [J]. CRITICAL CARE MEDICINE, 1999, 27 (04) : 723 - 732
  • [6] Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
    Dellinger, RP
    Carlet, JM
    Masur, H
    Gerlach, H
    Calandra, T
    Cohen, J
    Gea-Banacloche, J
    Keh, D
    Marshall, JC
    Parker, MM
    Ramsay, G
    Zimmerman, JL
    Vincent, JL
    Levy, MM
    [J]. CRITICAL CARE MEDICINE, 2004, 32 (03) : 858 - 873
  • [7] Dünser M, 2002, ANAESTHESIST, V51, P650, DOI 10.1007/s00101-002-0349-y
  • [8] Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis
    Ely, EW
    Laterre, PF
    Angus, DC
    Helterbrand, JD
    Levy, H
    Dhainaut, JF
    Vincent, JL
    Macias, WL
    Bernard, GR
    [J]. CRITICAL CARE MEDICINE, 2003, 31 (01) : 12 - 19
  • [9] Mechanical ventilator weaning protocols driven by nonphysician health-care professionals - Evidence-based clinical practice guidelines
    Ely, EW
    Meade, MO
    Haponik, EF
    Kollef, MH
    Cook, DJ
    Guyatt, GH
    Stoller, JK
    [J]. CHEST, 2001, 120 (06) : 454S - 463S
  • [10] Fox KM, 1996, EUR HEART J, V17, P96